ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY
Largest movements
- Cash -€62,992
down €62,992 (-24.5%), from €256,908 to €193,916
mainly Current investments (-€45,764) and Contributions, distributions and other (-€25,000)
- Current investments +€45,764
up €45,764 (+20.5%), from €222,949 to €268,714
- Reserves -€25,000
down €25,000 (-35.6%), from €70,182 to €45,182
of which Distributable reserves: -€25,000
- Other debts +€20,457
up €20,457 (+25.3%), from €80,893 to €101,350
- Profit (loss) carried forward -€14,176
down €14,176 (-3.2%), from €447,565 to €433,389
- Debts after one year -€8,346
down €8,346 (-12.2%), from €68,526 to €60,180
- Financial income -€4,009
down €4,009 (-40.5%), from €9,893 to €5,884
- Financial charges +€3,713
up €3,713 (+68.5%), from €5,417 to €9,130
- Gross operating margin -€880
down €880 (-184%), from -€478 to -€1,358
- Depreciation +€353
up €353 (+5.1%), from €6,943 to €7,296
- Taxes +€176
up €176 (+33.8%), from €519 to €695
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €699,686 | €674,134 | -€25,552 | -3.7% |
| Fixed assets | 21/28 | €214,911 | €208,995 | -€5,916 | -2.8% |
| Tangible fixed assets | 22/27 | €214,911 | €208,995 | -€5,916 | -2.8% |
| Land and buildings | 22 | €213,194 | €207,901 | -€5,293 | -2.5% |
| Plant, machinery and equipment | 23 | €388 | €258 | -€129 | -33.3% |
| Furniture and vehicles | 24 | €1,329 | €835 | -€493 | -37.1% |
| Current assets | 29/58 | €484,776 | €465,139 | -€19,637 | -4.1% |
| Amounts receivable within one year | 40/41 | €3,126 | €1,788 | -€1,338 | -42.8% |
| Other amounts receivable | 41 | €3,126 | €1,788 | -€1,338 | -42.8% |
| Current investments | 50/53 | €222,949 | €268,714 | +€45,764 | +20.5% |
| Cash at bank and in hand | 54/58 | €256,908 | €193,916 | -€62,992 | -24.5% |
| Deferred charges and accrued income | 490/1 | €1,792 | €721 | -€1,072 | -59.8% |
| Total equity and liabilities | 10/49 | €699,686 | €674,134 | -€25,552 | -3.7% |
| Equity | 10/15 | €536,340 | €497,164 | -€39,176 | -7.3% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €70,182 | €45,182 | -€25,000 | -35.6% |
| Tax-exempt reserves | 132 | €323 | €323 | = | 0.0% |
| Distributable reserves | 133 | €69,859 | €44,859 | -€25,000 | -35.8% |
| Profit (loss) carried forward | 14 | €447,565 | €433,389 | -€14,176 | -3.2% |
| Amounts payable | 17/49 | €163,347 | €176,970 | +€13,623 | +8.3% |
| Amounts payable after more than one year | 17 | €68,526 | €60,180 | -€8,346 | -12.2% |
| Financial debts | 170/4 | €68,526 | €60,180 | -€8,346 | -12.2% |
| Amounts payable within one year | 42/48 | €89,099 | €110,117 | +€21,018 | +23.6% |
| Current portion of amounts payable after more than one year | 42 | €8,207 | €8,346 | +€140 | +1.7% |
| Trade debts | 44 | €0 | €303 | +€303 | |
| Suppliers | 440/4 | €0 | €303 | +€303 | |
| Taxes, remuneration and social security | 45 | - | €119 | +€119 | |
| Taxes | 450/3 | - | €119 | +€119 | |
| Other amounts payable | 47/48 | €80,893 | €101,350 | +€20,457 | +25.3% |
| Accrued charges and deferred income | 492/3 | €5,721 | €6,673 | +€952 | +16.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,943 | €7,296 | +€353 | +5.1% |
| Other operating charges | 640/8 | €1,559 | €1,581 | +€22 | +1.4% |
| Gross operating margin | 9900 | -€478 | -€1,358 | -€880 | -184% |
| Operating profit (loss) | 9901 | -€8,981 | -€10,235 | -€1,254 | -14.0% |
| Financial income | 75/76B | €9,893 | €5,884 | -€4,009 | -40.5% |
| Recurring financial income | 75 | €9,893 | €5,884 | -€4,009 | -40.5% |
| Financial charges | 65/66B | €5,417 | €9,130 | +€3,713 | +68.5% |
| Recurring financial charges | 65 | €5,417 | €9,130 | +€3,713 | +68.5% |
| Profit (loss) for the period before taxes | 9903 | -€4,505 | -€13,481 | -€8,976 | -199% |
| Income taxes | 67/77 | €519 | €695 | +€176 | +33.8% |
| Profit (loss) for the period | 9904 | -€5,024 | -€14,176 | -€9,152 | -182% |
| Profit (loss) for the period to be appropriated | 9905 | -€5,024 | -€14,176 | -€9,152 | -182% |
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.